États-Unis · Bourse & Finance · MarketWatch

Genmab Shares Climb After Positive Study Results for Blood-Cancer Drug

Publié par MarketWatch · États-Unis il y a 9 h

Genmab shares jumped after the biotechnology company and partner AbbVie said their Epkinly drug helped extend the time patients with a common type of lymphoma lived without the…

Lire l'article complet sur MarketWatch Connectez-vous pour sauvegarder

MediaNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.marketwatch.com)

Genmab Shares Climb After Positive Study Results for Blood-Cancer Drug

À lire aussi

I'm the CEO of Zocdoc. Here's how long showers help me manage hectic days.

Euro Area retail sales rise 0.8% Y/Y, below estimates

Battle Between Disney and the F.C.C. Moves to the Courts

OKX Money lets users save, earn 10% yield and spend dollar stablecoins in one app

These are the 10 U.S. cities with the most homes at risk of hurricane damage

At Least 50 Iranian Tankers Are Stuck in the Gulf as U.S. Blockade Holds

Genmab Shares Climb After Positive Study Results for Blood-Cancer Drug

Partager

À lire aussi

I'm the CEO of Zocdoc. Here's how long showers help me manage hectic days.

Euro Area retail sales rise 0.8% Y/Y, below estimates

Battle Between Disney and the F.C.C. Moves to the Courts

OKX Money lets users save, earn 10% yield and spend dollar stablecoins in one app

These are the 10 U.S. cities with the most homes at risk of hurricane damage

At Least 50 Iranian Tankers Are Stuck in the Gulf as U.S. Blockade Holds